Allison Eddy
Last active: 2/3/2012

  1. A novel signaling pathway: fibroblast nicotinic receptor alpha1 binds urokinase and promotes renal fibrosis. Zhang G, Kernan KA, Thomas A, Collins S, Song Y, Li L, Zhu W, Leboeuf RC, Eddy AA (2009) J Biol Chem 284(42): 29050-64
    › Primary publication · 19690163 (PubMed) · PMC2781451 (PubMed Central)
  2. Urokinase and its receptors in chronic kidney disease. Zhang G, Eddy AA (2008) Front Biosci : 5462-78
    › Primary publication · 18508599 (PubMed) · PMC3142275 (PubMed Central)
  3. Macrophage diversity in renal injury and repair. Ricardo SD, van Goor H, Eddy AA (2008) J Clin Invest 118(11): 3522-30
    › Primary publication · 18982158 (PubMed) · PMC2575702 (PubMed Central)
  4. Angiotensin converting enzyme inhibitor but not angiotensin receptor blockade or statin ameliorates murine adriamycin nephropathy. Tang SC, Leung JC, Chan LY, Eddy AA, Lai KN (2008) Kidney Int 73(3): 288-99
    › Primary publication · 18033243 (PubMed)
  5. Plasmin(ogen) promotes renal interstitial fibrosis by promoting epithelial-to-mesenchymal transition: role of plasmin-activated signals. Zhang G, Kernan KA, Collins SJ, Cai X, López-Guisa JM, Degen JL, Shvil Y, Eddy AA (2007) J Am Soc Nephrol 18(3): 846-59
    › Primary publication · 17267741 (PubMed)
  6. Endogenous urokinase lacks antifibrotic activity during progressive renal injury. Yamaguchi I, Lopez-Guisa JM, Cai X, Collins SJ, Okamura DM, Eddy AA (2007) Am J Physiol Renal Physiol 293(1): F12-9
    › Primary publication · 17356128 (PubMed)
  7. Atherogenic scavenger receptor modulation in the tubulointerstitium in response to chronic renal injury. Okamura DM, López-Guisa JM, Koelsch K, Collins S, Eddy AA (2007) Am J Physiol Renal Physiol 293(2): F575-85
    › Primary publication · 17537985 (PubMed)
  8. Ramping up endogenous defences against chronic kidney disease. Eddy AA (2006) Nephrol Dial Transplant 21(5): 1174-7
    › Primary publication · 16574685 (PubMed)
  9. Plasminogen activator inhibitor-1 in chronic kidney disease: evidence and mechanisms of action. Eddy AA, Fogo AB (2006) J Am Soc Nephrol 17(11): 2999-3012
    › Primary publication · 17035608 (PubMed)
  10. Plasminogen activator inhibitor-1 deficiency has renal benefits but some adverse systemic consequences in diabetic mice. Collins SJ, Alexander SL, Lopez-Guisa JM, Cai X, Maruvada R, Chua SC, Zhang G, Okamura DM, Matsuo S, Eddy AA (2006) Nephron Exp Nephrol 104(1): e23-34
    › Primary publication · 16735799 (PubMed)